Needham on Monday initiated coverage on Atai Life Sciences NV (NASDAQ:ATAI), a clinical-stage biopharmaceutical company focused on developing treatments for mental health. The company’s lead drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback